随着我国基本医疗保险(简称医保)制度改革的不断深入,有关用药管理的改革也日趋完善。医疗费用“总量控制,结构调整”对降低药费占医疗费用的过高比例发挥了重要的作用,取得了一定的成效。然而,由于各种因素所致,与医保制度改革休戚相关的医疗卫生体制改革及药品生产流通体制的 With the deepening of the reform of China’s basic medical insurance (Medicare) system, the reform on drug administration is also perfecting. The “total amount control and structural adjustment” of medical expenses has played an important role in reducing the excessive proportion of medical expenses and taking some achievements. However, due to various factors, the medical and health system reform and the pharmaceutical production and distribution system, which have a bearing on the health care reform,